Vol 65, No 7 (2007)
Other
Published online: 2007-07-24

open access

Page views 259
Article views/downloads 529
Get Citation

Connect on Social Media

Connect on Social Media

Evidence-based medicine
Badanie ARMYDA-ACS wskazuje na korzystny wpływ przedproceduralnego podania 80 mg atorwastatyny u chorych z ostrymi zespołami wieńcowymi leczonymi pierwotną angioplastyką. Commentary to the article: Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007; 49: 1272-8.

Aleksandra Michałek
DOI: 10.33963/v.kp.80863
Kardiol Pol 2007;65(7):851-852.

Abstract

Not available

Article available in PDF format

View PDF (Polish) Download PDF file



Polish Heart Journal (Kardiologia Polska)